Uncategorized

BioHarvest Sciences Announces Uplisting to the Nasdaq Global Market

Common Shares to Begin Trading on Nasdaq on Tuesday, November 12, 2024 Vancouver, British Columbia and Rehovot, Israel – November 7, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF), a company pioneering its patented Botanical Synthesis technology platform, today announced that the Nasdaq Stock Market LLC has approved the listing of […]

BioHarvest Sciences Announces Uplisting to the Nasdaq Global Market Read More »

BioHarvest

BioHarvest Sciences Reports Fourth Quarter and Full Year 2023 Financial Results

Vancouver, British Columbia and Rehovot, Israel – April 30, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF), a biotechnology company pioneering its patented Botanical Synthesis technology platform, today reported its financial and operational results for the fourth quarter and full year ended December 31, 2023. The Company is also announcing an

BioHarvest Sciences Reports Fourth Quarter and Full Year 2023 Financial Results Read More »

BioHarvest Sciences to Participate in Benzinga Virtual Healthcare Summit 2024 on March 20, 2024

Vancouver, British Columbia and Rehovot, Israel – March 14, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF), a biotechnology company pioneering its patented Botanical Synthesis technology platform, today announced that it has been invited to participate in the Benzinga Virtual Healthcare Summit 2024 on March 20, 2024. Benzinga’s Virtual Healthcare Summit

BioHarvest Sciences to Participate in Benzinga Virtual Healthcare Summit 2024 on March 20, 2024 Read More »